Recruiting

Virtual Education

Sponsor:

Children's Hospital Los Angeles

Code:

NCT06408207

Conditions

Type1 Diabetes

Eligibility Criteria

Sex: All

Age: 8 - 18

Healthy Volunteers: Not accepted

Interventions

CGM Academy

Study Details

Brief summary:

The goal of this randomized clinical trial is to compare the effects of a virtual education curriculum in blood glucose variation of youth with type 1 diabetes wearing continuous glucose monitoring (CGM) device. The main questions the study aims to answer are:

  • Do participants undertaking the proposed curriculum present improved glucose variation than participants of standard education?
  • Explore relationships between participant's glycemic outcomes with diabetes distress, diabetes family responsibilities, and number of hours of diabetes education.

Participants in the intervention group will:

  • receive an interactive workbook with problem-based learning scenarios and video links about CGM and glucose management strategies.
  • participate in four in-depth online group sessions with diabetes care and education specialists
  • complete questionnaires three times: at the time of study enrollment, week 4 and 6 months.

Participants in the comparison group will:

  • receive standard education provided to all patients at CHLA
  • complete questionnaires three times: at the time of study enrollment, week 4 and 6 months.

Conditions

Type1 Diabetes

Study ID

NCT06408207

Start date

May 1, 2025

Status verified date

Jul, 2025

Completion date

Dec 30, 2026

Anticipated

Primary completion date

Sep 30, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 8 - 18

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Current age of 8-18 years, age group eligible for CGM therapy with Dexcom G6 and G7
  • T1D duration ≥6 months, as insulin adjustments during honeymoon stage differs from establishedT1D
  • Able to speak, read, and write English or Spanish
  • Smartphone compatible with Dexcom G6 and G7application
  • Ability to participate in virtual visits

Exclusion Criteria:

• Known history of medical adhesive allergies

Study Design

Enrollment

90 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: CGM Academy

  • receive an interactive workbook with problem-based learning scenarios and video links about CGM and glucose management strategies.
  • participate in four in-depth online group sessions with diabetes care and education specialists
  • complete questionnaires three times: at the time of study enrollment, week 4 and 6 months.

no intervention: Standard Diabetes Education

  • receive standard education provided to all patients at CHLA
  • complete questionnaires three times: at the time of study enrollment, week 4 and 6 months.

Interventions

CGM Academy

Educational materials as well as online sessions with diabetes educators.

Primary outcome measure

  • Mean change in Hemoglobin A1c from baseline to 6 months [ Time Frame: Baseline to 6 months ]

Central Contacts and Locations

Central contacts

Rebecca Barber, PhD, RN

(323) 361-1359rbarber@chla.usc.edu

Natalia Garban

ngarban@chla.usc.edu

Locations

Children's Hospital Los Angeles

Recruiting

Los Angeles, California, United States, 90027

Contacts

Natalia Garban

ngarban@chla.usc.edu

Principal Investigator:

Rebecca Barber, PhD, RN

More Information

Sponsor

Children's Hospital Los Angeles

Last update posted

Feb 6, 2026

Last verified

Jul, 2025

Keywords

  • Continuous Glucose Monitoring
  • Glycemic Control
  • Diabetes Education
  • Type1 Diabetes

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Children's Hospital Los Angeles on 2026-02-06.